159 related articles for article (PubMed ID: 22374423)
1. PAX7-FKHR fusion gene inhibits myogenic differentiation via NF-kappaB upregulation.
Charytonowicz E; Matushansky I; Doménech JD; Castillo-Martín M; Ladanyi M; Cordon-Cardo C; Ziman M
Clin Transl Oncol; 2012 Mar; 14(3):197-206. PubMed ID: 22374423
[TBL] [Abstract][Full Text] [Related]
2. Mouse mesenchymal stem cells expressing PAX-FKHR form alveolar rhabdomyosarcomas by cooperating with secondary mutations.
Ren YX; Finckenstein FG; Abdueva DA; Shahbazian V; Chung B; Weinberg KI; Triche TJ; Shimada H; Anderson MJ
Cancer Res; 2008 Aug; 68(16):6587-97. PubMed ID: 18701482
[TBL] [Abstract][Full Text] [Related]
3. Alternate PAX3 and PAX7 C-terminal isoforms in myogenic differentiation and sarcomagenesis.
Charytonowicz E; Matushansky I; Castillo-Martin M; Hricik T; Cordon-Cardo C; Ziman M
Clin Transl Oncol; 2011 Mar; 13(3):194-203. PubMed ID: 21421465
[TBL] [Abstract][Full Text] [Related]
4. Alveolar rhabdomyosarcoma: is the cell of origin a mesenchymal stem cell?
Charytonowicz E; Cordon-Cardo C; Matushansky I; Ziman M
Cancer Lett; 2009 Jul; 279(2):126-36. PubMed ID: 19008039
[TBL] [Abstract][Full Text] [Related]
5. High expression of the PAX3-FKHR oncoprotein is required to promote tumorigenesis of human myoblasts.
Xia SJ; Holder DD; Pawel BR; Zhang C; Barr FG
Am J Pathol; 2009 Dec; 175(6):2600-8. PubMed ID: 19893043
[TBL] [Abstract][Full Text] [Related]
6. AKT and PAX3-FKHR cooperation enforces myogenic differentiation blockade in alveolar rhabdomyosarcoma cell.
Jothi M; Nishijo K; Keller C; Mal AK
Cell Cycle; 2012 Mar; 11(5):895-908. PubMed ID: 22333587
[TBL] [Abstract][Full Text] [Related]
7. Pax7-FKHR transcriptional activity is enhanced by transcriptionally repressed MyoD.
Olguín HC; Patzlaff NE; Olwin BB
J Cell Biochem; 2011 May; 112(5):1410-7. PubMed ID: 21321994
[TBL] [Abstract][Full Text] [Related]
8. Effects of PAX3-FKHR on malignant phenotypes in alveolar rhabdomyosarcoma.
Kikuchi K; Tsuchiya K; Otabe O; Gotoh T; Tamura S; Katsumi Y; Yagyu S; Tsubai-Shimizu S; Miyachi M; Iehara T; Hosoi H
Biochem Biophys Res Commun; 2008 Jan; 365(3):568-74. PubMed ID: 18022385
[TBL] [Abstract][Full Text] [Related]
9. Gene fusions involving PAX and FOX family members in alveolar rhabdomyosarcoma.
Barr FG
Oncogene; 2001 Sep; 20(40):5736-46. PubMed ID: 11607823
[TBL] [Abstract][Full Text] [Related]
10. PAX-FKHR function as pangenes by simultaneously inducing and inhibiting myogenesis.
Graf Finckenstein F; Shahbazian V; Davicioni E; Ren YX; Anderson MJ
Oncogene; 2008 Mar; 27(14):2004-14. PubMed ID: 17922034
[TBL] [Abstract][Full Text] [Related]
11. Transgenic mice expressing PAX3-FKHR have multiple defects in muscle development, including ectopic skeletal myogenesis in the developing neural tube.
Finckenstein FG; Davicioni E; Osborn KG; Cavenee WK; Arden KC; Anderson MJ
Transgenic Res; 2006 Oct; 15(5):595-614. PubMed ID: 16952014
[TBL] [Abstract][Full Text] [Related]
12. Identification of PAX3-FKHR-regulated genes differentially expressed between alveolar and embryonal rhabdomyosarcoma: focus on MYCN as a biologically relevant target.
Mercado GE; Xia SJ; Zhang C; Ahn EH; Gustafson DM; Laé M; Ladanyi M; Barr FG
Genes Chromosomes Cancer; 2008 Jun; 47(6):510-20. PubMed ID: 18335505
[TBL] [Abstract][Full Text] [Related]
13. Identification of a PAX-FKHR gene expression signature that defines molecular classes and determines the prognosis of alveolar rhabdomyosarcomas.
Davicioni E; Finckenstein FG; Shahbazian V; Buckley JD; Triche TJ; Anderson MJ
Cancer Res; 2006 Jul; 66(14):6936-46. PubMed ID: 16849537
[TBL] [Abstract][Full Text] [Related]
14. Genetic heterogeneity in the alveolar rhabdomyosarcoma subset without typical gene fusions.
Barr FG; Qualman SJ; Macris MH; Melnyk N; Lawlor ER; Strzelecki DM; Triche TJ; Bridge JA; Sorensen PH
Cancer Res; 2002 Aug; 62(16):4704-10. PubMed ID: 12183429
[TBL] [Abstract][Full Text] [Related]
15. Global gene expression profiling of PAX-FKHR fusion-positive alveolar and PAX-FKHR fusion-negative embryonal rhabdomyosarcomas.
Laé M; Ahn EH; Mercado GE; Chuai S; Edgar M; Pawel BR; Olshen A; Barr FG; Ladanyi M
J Pathol; 2007 Jun; 212(2):143-51. PubMed ID: 17471488
[TBL] [Abstract][Full Text] [Related]
16. The oncogenic fusion protein Pax3-FKHR has a greater post-translational stability relative to Pax3 during early myogenesis.
Miller PJ; Hollenbach AD
Biochim Biophys Acta; 2007 Oct; 1770(10):1450-8. PubMed ID: 17698292
[TBL] [Abstract][Full Text] [Related]
17. A Drosophila model of the rhabdomyosarcoma initiator PAX7-FKHR.
Galindo RL; Allport JA; Olson EN
Proc Natl Acad Sci U S A; 2006 Sep; 103(36):13439-44. PubMed ID: 16938866
[TBL] [Abstract][Full Text] [Related]
18. Carnitine palmitoyltransferase 1A (CPT1A): a transcriptional target of PAX3-FKHR and mediates PAX3-FKHR-dependent motility in alveolar rhabdomyosarcoma cells.
Liu L; Wang YD; Wu J; Cui J; Chen T
BMC Cancer; 2012 Apr; 12():154. PubMed ID: 22533991
[TBL] [Abstract][Full Text] [Related]
19. Analysis of genetic events that modulate the oncogenic and growth suppressive activities of the PAX3-FKHR fusion oncoprotein.
Xia SJ; Rajput P; Strzelecki DM; Barr FG
Lab Invest; 2007 Apr; 87(4):318-25. PubMed ID: 17297479
[TBL] [Abstract][Full Text] [Related]
20. Nephroblastoma overexpressed (NOV/CCN3) gene: a paired-domain-specific PAX3-FKHR transcription target that promotes survival and motility in alveolar rhabdomyosarcoma cells.
Zhang Y; Wang C
Oncogene; 2011 Aug; 30(32):3549-62. PubMed ID: 21423212
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
